Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > December 1989 - Volume 298 - Issue 6 > Atrial Natriuretic Peptide Lowers Pulmonary Arterial Pressur...
American Journal of the Medical Sciences:
Original Manuscripts: PDF Only

Atrial Natriuretic Peptide Lowers Pulmonary Arterial Pressure in Patients with High Altitude Disease

LIU, LISHENG MD; CHENG, HUAYANG MD; CHIN, WEIJUAN MD; JIN, HONGKUI MD; OPARIL, SUZANNE MD

Collapse Box

Abstract

The authors' previous studies have demonstrated that IV administration of atrial natriuretic peptide (ANP) produces a dose dependent decrease in pulmonary arterial pressure in rats adapted to chronic hypoxia. To examine the effects of ANP on chronic hypoxic pulmonary hypertension in man, [alpha]-human ANP (200 [mu]g) was infused (20 [mu]g/min x 10 min) into the right atrium via a Swan-Ganz catheter in four patients with pulmonary hypertension of high altitude. Following the infusion, pulmonary arterial pressure fell gradually and remained depressed for 1 hour. Peak reductions in pulmonary arterial systolic pressure (PASP) and mean pulmonary arterial pressure (MPAP) were 23% and 30%, respectively. Systemic arterial pressure, cardiac output and cardiac index also tended to decrease, but these changes did not reach statistical significance. The data suggest that ANP is useful in the treatment of chronic hypoxic pulmonary hypertension in man.

(C) Copyright 1989 Southern Society for Clinical Investigation

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.